GENE: Rata-rata rega prakiraan GTG Labs

The price chart for Genetic Technologies (GENE) illustrates the price action of an asset whose revenue is based on the implementation of genomic research for the early detection of cardiac pathologies and breast oncology, which constitutes 6.85. High throughput is achieved through the integration of robotics into the DNA sequencing process. Meanwhile, Genetic Technologies (GENE) complies with biomaterial disposal regulations and maintains basic environmental standards across its offices.

GENE (Genetic Technologies) riwayat Prakiraan konsensus analis saka 04.07.2022 nganti 26.10.2024

Rincian analitis perusahaan Genetic Technologies (GENE)

GENE (gtglabs.com) — indikator lan laporan sing kasedhiya:

Bagan kurs gtglabs.com|GENE - Prakiraan konsensus analis|Nilai pasar GTG Labs

Analisis umum perusahaan:Genetic Technologies Ltd (GENE)

Produk asli GTG Labs

Genetic Technologies possesses strong pricing power in the preventive genetics segment, and the low demand elasticity for geneType tests creates a foundation for a premium business valuation. The volume-weighted average share price of 6.85 digitizes the institutional consensus, where the consensus fair value forecast captures shifts in analyst sentiment, allowing investors to timely identify market trend inflection points.

Perusahaan pesaing

agilent.com (A) - Rentang target analis|Prakiraan konsensus analis DGX (Quest Diagnostics Incorporated)|Illumina Inc (ILMN) - Rata-rata rega prakiraan|EXAS - Bagan rega target|RVTY (Revvity Corp) - Prakiraan gabungan firma investasi|BIO: Prakiraan konsensus analis|Rata-rata rega prakiraan anbio.com (NNNN)|Bagan rega target Sotera Health|Target konsensus Quidel Corporation (QDEL)|Prakiraan konsensus analis OPK|CDNA - Rata-rata rega prakiraan|Prakiraan konsensus analis MRVI (Maravai LifeSciences)|FLGT: Prakiraan gabungan firma investasi|Standard BioTools - Prakiraan konsensus analis|CTKB - Prakiraan konsensus analis|OraSure Technologies Inc (OSUR) - Bagan rega target|Prakiraan gabungan firma investasi XGN|MDXH (MDxHealth SA) - Prakiraan konsensus analis|Prakiraan konsensus analis luciddx.com|Bagan rega target Prenetics Global (PRE)|Bagan rega target IMDX (imdxinc.com)|Trinity Biotech - Target konsensus|ProPhase Labs Corp (PRPH) - Rata-rata rega prakiraan|AIMD - Bagan rega target|Target median analis codiagnostics.com CODX|HSCS: Prakiraan konsensus analis|BMRA - Target median analis|Bagan rega target Cardio Diagnostics Holdings Inc.|Virax Biolabs Corp (VRAX) - Target median analis|Prakiraan konsensus analis BJDX|aspirawh.com (AWH) - Rentang target analis|Prakiraan konsensus analis AXDX (Accelerate Diagnostics, Inc.)|CENTOGENE, N.V. (CNTG) - Rata-rata rega prakiraan|ENZ - Bagan rega target|FRES (Fresh2 Group Limited) - Prakiraan gabungan firma investasi|ME: Prakiraan konsensus analis|Rata-rata rega prakiraan psychemedics.com (PMD)